Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$235,236
+$8,097 QoQ
Shares Held
1,501
+0.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,246
of 1,606 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAUSEWAY CAPITAL MANAGEMENT LLC holds $2,118,676,056 across 8 Drug Manufacturers - General names. NVS ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
9,357,390 | $1,774,348,291 | |
| 2 | MRK |
Merck & Co., Inc.
|
954,932 | $122,708,762 | |
| 3 | NVO |
Novo Nordisk A S
|
1,677,615 | $80,424,863 | |
| 4 | BIIB |
Biogen Inc.
|
278,283 | $60,125,824 | |
| 5 | PFE |
Pfizer Inc
|
1,916,801 | $46,156,568 | |
| 6 | SNY |
Sanofi
|
804,056 | $34,301,028 | |
| 7 | GSK |
GSK plc
|
7,163 | $375,484 | |
| 8 | NVS |
Novartis AG
This page
|
1,501 | $235,236 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $235,236 | 1,501 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $227,139 | 1,487 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $266,778 | 1,935 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $263,404 | 2,054 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $252,184 | 2,084 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $472,229 | 4,236 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $570,820 | 5,866 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $849,077 | 7,382 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $21,540,584 | 202,335 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $23,163,739 | 239,468 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $21,111,716 | 209,089 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $19,049,755 | 187,019 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $22,760,048 | 225,548 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $22,605,044 | 245,707 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $20,215,319 | 222,832 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $20,585,788 | 270,830 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $26,402,184 | 312,341 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $34,377,115 | 391,762 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $33,410,653 | 381,967 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $32,803,266 | 401,116 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $38,957,837 | 426,982 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $33,966,161 | 397,358 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $28,855,730 | 305,578 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $27,393,965 | 315,018 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $28,489,085 | 326,186 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $26,939,218 | 326,734 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||